Empagliflozin/metformin demonstrates reductions in blood glucose in data presented at ADA
Empagliflozin/metformin demonstrates reductions in blood glucose in data presented at ADA
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news